JAK1 and acute lymphoblastic leukemia: Since the identified JAK1 mutations were focused in exon 14 and 21, we sequenced the two exons in additional 152 ALL patients (B-ALL, n = 140; T-ALL, n = 12) to determine the prevalence of JAK1 mutations.